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Introduction    Many  of  us  recognize  stress  as  an  inconvenient  emotion  we  have  to  endure,  but  it  is actually  a  product  of  a  highly  developed  and  regulated  physiological  system  that  has  critical purposes  for  survival.    This  system  utilizes  the  hypothalamic‐pituitary‐adrenal  (HPA)  axis  to exert its effects.   In the natural world, animals are faced with stressors such as escaping from a predator or surviving starvation.   Humans, on  the other hand, experience a variety of complex stressor types, many of which are psychologically based.  Chronic psychological stress is the form we are familiar with, and the type most people experience on a daily basis.   We are faced with problems such as how to provide for our families, performing intellectually challenging tasks for work or school with limited time, or the various social pressures we knowingly or inadvertently worry about.   Acute psychological stress  is distinct  from chronic stress  in  that  it  is a relatively short‐term  occurrence  with  ranging  intensities  –  from  mild  stressors,  such  as  performing mathematical tasks with a time constraint, to extreme stressors such as war combat, rape, or the death of a family member.   Both  chronic  and  acute  stress  can  interfere  with  healthy  HPA  function  and  can  have deleterious effects on the body.  Acute stress in particular can contribute to various psychological conditions such as post‐traumatic stress disorder, anxiety, and major depressive disorder (1,7).  Often  these  disorders  are  characterized  by  imbalances  in  HPA  axis‐controlled  hormones, particularly  a  class  of  steroid  hormones  known  as  glucocorticoids,  (cortisol  in  humans  and corticosterone in rats, abbreviated CORT).  Glucocorticoids are the primary effector hormones of the HPA axis, and while their secretion is highly regulated, they exert regulatory influence over the HPA system – hence this regulatory pattern has a cyclical mechanism.  Although some of the forms  of  regulation  (such  as  negative  inhibition  of  releasing  hormone)  are  understood,  the mechanisms and anatomical sites of regulation have not been well defined.  In order to address the dysregulation occurring  in  individuals with HPA axis disorders,  it  is preeminent  that  these mechanisms are understood.  This project addresses some of these HPA regulatory mechanisms at the level of the hypothalamus.   The  purpose  of  this  project  was  to  observe  how  various  components  of  the  HPA  axis respond to and are regulated by both tonic and phasic secretions of glucocorticoids.  A particular protein, TORC2,  is  a  coregulator  for  gene  transcription  in  the hypothalamus and  is  the  central focus of this project.  Research on TORC2 in vivo has been limited, however some components of 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its  behavior  have  been  established  in  vitro.    We  expected  to  see  that  it  would  be  responsive (activated) by 15 minutes of acute psychological stress in laboratory rats, but that it would not be as sensitive to removal of tonic secretion of glucocorticoids by adrenalectomy.  However, the data  collected  from  this  experiment  did  not  show  any  significant  differences  between  test groups.   
Background 
Stress response anatomy, physiology and the HPA axis   There is a marked distinction between physical stress, in which an injury or illness alters a homeostatically regulated setpoint (such as blood volume), and psychological stress, in which higher  brain  centers  of  an  organism  interpret  a  situation  as  a  threat  to  its  well‐being  (23).  Psychological stress is utilized in this project because it is more relevant to human circumstances and  disorders,  as  the  majority  of  the  stressors  that  humans  experience  is  not  physical,  but psychological.    Physical  stress,  therefore,  is  not within  the  scope  of  this  paper  and  all  further discussion will be in the context of acute psychological stress.     Almost  immediately upon  the organism’s perception of a  stressful event,  a multitude of physiological changes take place in order to assist the animal in coping with the challenge.  The first  wave  of  response  occurs  through  activation  of  the  sympathetic  branch  of  the  autonomic nervous system, and is both rapid and transient.  Postganglionic sympathetic innervation causes an  increase  in  heart  rate,  induces  the  pancreas  to  release  glucagon  into  the  bloodstream,  and stimulates  the  adrenal  medulla,  increasing  secretion  of  catecholamines  (norepinephrine  and epinephrine),  which  also  generate  similar  outcomes  as  sympathetic  innervation  (23).    In addition,  catecholamines  affect  peripheral  and  central  vasculature,  causing  vasoconstriction  of digestive  and neural  tissue  vessels, while  enlarging  the  vessels  of  skeletal muscles.    Increased blood  flow  to  skeletal  muscles  coupled  with  increased  heart  rate  and  blood  glucose  levels enhance  the  chance  of  an  animal’s  survival  in  dangerous  situations  by  diverting  energy  to appropriate  tissues.   The sympathetic nervous system is vital  in  the stress response because  it drives these variables away from homeostasis in order for the animal to escape harm.  The HPA axis  is  simultaneously  activated  during  stress,  and  although  it  has  some  influence  during  the immediate  stress,  its  primary  responsibilities  are  to  return  the  organism  to  homeostasis  and prepare it for future stress (23). 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eminence, the superior portion of the neurohypophysis (20).  Here, previously synthesized CRH peptide is stored in vesicles, ready for release into the hypophyseal portal system.  Upon cellular excitation,  specifically  depolarization,  CRH  is  released  into  the  portal  blood  and  travels  to  the 
pars  distalis  region  of  the  adenohypophysis  (also  known  as  the  anterior  pituitary  in  most mammals),  and  stimulates  corticotrophs  to  release  ACTH  into  systemic  circulation  (20).    The primary function of ACTH is to stimulate the production and release of steroid hormones called glucocorticoids, namely CORT, from the cortex of the adrenal glands.  Glucocorticoids can cause changes that enable the organism to react to the immediate stressor, but are heavily involved in shutting  off  the  stress  response  and  returning  the  organism  to  homeostasis  through  negative feedback inhibition (23).    
Glucocorticoids: mechanistic properties, classes of action, and tonic versus phasic secretion   As mentioned, the primary role of glucocorticoids is to terminate the stress response and to  restore  homeostasis.    They  do,  however,  have  some  important  roles  in  altering  various physiological  functions  during  stress,  one  of  which  is  enhancing  the  secretion  and  activity  of catecholamines  (23).    Glucocorticoids  also  have  a  role  in  sharpening  cognition  via  increased cerebral  glucose  utilization  and  suppression  of  immunity,  but  they  predominantly  influence metabolic  function  (23).    Glucocorticoids  induce  gluconeogenesis  in  the  liver  and  increase catabolic  breakdown  of  fats,  protein  and  carbohydrates  (20).    However,  most  glucocorticoid effects  are genomic  in nature,  therefore  requiring activation of DNA  transcription and de novo protein synthesis.  The effects of glucocorticoids occur in a slower wave of events that follows the initial, sympathetic response to stress, somewhere within a time frame of approximately 1 hour after the onset of stress, enough time to allow for gene transcription and protein synthesis from mRNA (20,22).  It is possible, even likely, that the animal has already evaded the stressor by this time.   Therefore, many of  the  actions of  glucocorticoids do not  influence  the  immediate  stress response, but  instead return  the animal  to a baseline physiological state, and also enhance  the chances of survival in a subsequent challenge.   Within  the  context  of  stress,  glucocorticoid  actions  are  separated  into  four  distinct classes:  stimulatory,  suppressive,  preparative,  and  permissive  (18,23).    Stimulatory  and suppressive  glucocorticoid  actions  are  virtually  instantaneous  upon  systemic  release  from  the adrenal  cortex;  these  actions  can  only  be  considered  stimulatory  or  suppressive  if  they  are 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involved  in  coping with  the  immediate  stress  (23).    These  functions  are  ultimately  related  to acute  secretions  of  ACTH,  which  directly  induce  secretion  of  glucocorticoids.    Glucocorticoids inherently  feed  back  upon  the  hypothalamus  and  pituitary  gland  to  terminate  the  increased secretion of ACTH.   However,  levels of both ACTH and glucocorticoids return to basal  levels by about  30  minutes  after  the  termination  of  stress,  and  glucocorticoid  negative  feedback contributes to this timely shut‐off of the response (5).   The  latter  two  classes  of  glucocorticoid  action  exert  their  effects  in  a  much  slower manner.    Glucocorticoid  actions  are  considered  preparatory  if  they  enhance  the  animal’s response to a future stressor and do not aid the reaction to the present stressor.  An example of this  is  that  glucocorticoids  induce  the  liver  to  increase  its  rates  of  glycogen  synthesis,  thus upregulating energy stores within the animal to aid the response to a subsequent stressor (23).  Permissive actions of glucocorticoids are those that do not directly cause physiological changes, but  enhance  the  effects  of  other  systems  or  hormones.    Permissive  glucocorticoid  actions  are manifested through a circadian, diurnal cycle of secretion (23).  A tonic surge of glucocorticoids occurs each day, peaking just prior to the start of the active  period;  for  rats  this  occurs  prior  to  lights  off (Figure  3).    It  is  thought  that  this  tonic  secretion ensures  that  the  organism  can  manage  metabolic variations  that will  occur  once  feeding begins  (5).    A relevant  example  of  permissive  action  is  the  tonic regulation of ACTH secretion.  In rats without adrenal glands,  ACTH  is  significantly  upregulated.  However, replacement  of  circadian‐cycle  levels  of glucocorticoids  mostly  normalized  ACTH  levels  that are  usually  regulated  by  phasic  increases  in glucocorticoids (10).    










transcription;  gene expression  inhibition occurs at  a negative glucocorticoid  response element (nGRE)  (4,11,21).    It  has  been widely  established  that  removal  of  endogenous  glucocorticoids increases both basal  and  acute  levels  of ACTH and corticosterone  (5,22).    Interestingly,  when  gluco‐corticoids  were  replaced  in  adrenalectomized  rats (in the drinking water)  in a manner that mimicked the  circadian  rise  at  the  beginning  of  the  active period  but  not  phasic  secretions,  basal and  stress‐induced  ACTH  levels  were  largely  normalized, indicating  a  permissive  manner  of  glucocorticoid feedback (Figure 4).   Girotti et. al also showed that 










mechanisms of gene expression feedback require further investigation.  The genomic component of both HPA axis activity and regulation is central to this project, and it  is  important to discuss the mechanisms of transcription with perspectives on phasic and tonic actions of glucocorticoids.  Crh gene transcription and TORC: regulatory mechanisms   It  is  known  that  acute  psychological  stress  induces  notable  increases  in  crh  gene expression within the PVN; hnRNA levels peak at around 15 minutes of restraint stress and fall to almost basal levels by 30 minutes (5,15,22).  While many of the processes of transcription are understood, what is unknown are the exact means by which cellular activity  leads to induction and regulation of crh gene transcription.     An  array  of  neural  signals,  from  depolarization  of  the  cell  to  activation  of  second messenger  pathways,  is  required  to  initiate  crh  gene  transcription  (6).    The  protein  kinase  A (PKA)  pathway,  which  utilizes  cyclic‐adenosine  mono‐phosphate  (cAMP)  and  PKA,  has  been shown  to  activate  transcription  through  phosphorylation  of  the  transcription  factor  cAMP response element‐binding protein (CREB) by PKA (15,16).  It has been demonstrated in vitro in hypothalamic  4B  cell  lines  that  activation  of  CREB  via  cAMP  pathway  is  necessary,  but  not sufficient,  for  crh  gene  transcription,  measured  by  promoter  activity  of  the  crh  gene (15,16,17,24).  In vivo studies have indicated that there is an increase in crh gene expression that directly  corresponds  to  phosphorylation  of  CREB  upon  stress  induction  (2,14).    Clearly, phosphorylated CREB plays an integral role in crh gene expression; however CREB is involved in transcription of  an  immense number of  genes within  various  tissues  (24).    Therefore,  it  likely requires  a  coactivator  to  induce  specific  genomic  activity,  and  a  class  of  proteins  called transducers of regulated CREB activity (TORCs) are valid candidates (15,16,17,24).   There  are  three  isoforms  of  TORC,  all  of which  interact with  pCREB  and  are  proposed coactivators for pCREB activity (15,16).  TORC proteins have been found extensively in the liver and  shown  to  be  actively  involved  in  expression  of  gluconeogenic  genes  in  hepatic  cells,  in cooperation with cAMP and therefore CREB (13).   Although all three isoforms are present in the brain, TORC2  is  the predominant species  in hypothalamic  tissue  (particularly  in  the PVN), and appears  most  responsive  to  stimulation  by  the  PKA‐activating  drug  forskolin  in  vitro  (16).  Somewhat  counter‐intuitively,  TORC  proteins  are  sequestered  in  the  cytoplasm  as  a  result  of phosphorylation  by  specific  kinases,  such  as  salt‐inducible  kinase  and  AMP  kinase;  this 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phosphorylation  increases  its  affinity  with  the scaffolding  protein  14‐3‐3,  which  retains  TORC  in the cytoplasm (16,24)  (Figure 8).   Activation of  the cell,  specifically  the  cAMP  pathway,  activates  PKA, inhibiting  salt‐inducible  kinase,  preventing  tonic phosphorylation  of  14‐3‐3,  and  allowing  TORC  to shuttle  to  the  nucleus  (24).    A  phosphatase  is  also probably  required,  and  calcineurin  (activated  by calcium ion influx into the cell) is a likely candidate (24).    Once  TORC  has  translocated  from  the cytoplasm to the nucleus, it is able to bind to pCREB and  initiate  gene  transcription  at  the  crh promoter (16).    However,  it  is  unknown  how  this  protein behaves  in vivo  in  response  to stressful  stimuli and in  the  presence  of  tonic  and  phasic  increases  in glucocorticoids.  The aim of this project is to observe TORC2 behavior in vivo, manipulating both tonic and phasic secretions of glucocorticoids.  






  Another  pilot  study  was  conducted  using  the  newly  established  fixation  conditions,  in order to test and perfect the actual IHC procedure; it was also an initial test to explore the effects of stress upon TORC2 activity in vivo.  In this experiment (n=4) TORC2 activation was compared between no‐stress and stress conditions in adrenal‐intact animals.   Although this study did not yield  statistically  significant  data,  the  trends  were  strong  enough  to  move  forward  with investigation.    These  studies  became  the  basis  for  the main  experiment  of  this  project, which looked  at  both  tonic  glucocorticoid  actions  and  stress  effects  (phasic  actions)  on  TORC2 activation.   
Preliminary  Experiment  1:  cellular  stimulation  in  vitro 
induces nuclear translocation of TORC2   TORC  proteins  were  discovered  relatively recently,  and  there  have  been  a  limited  number  of studies  regarding  its  activity  in  the  brain,  especially  in 






forskolin  (10 uM)  onto  the  tissue;  the  negative  control was  vehicle, which was  culture media.  The tissue was exposed to neither CORT pretreatment nor forskolin, to one of the two, or to both CORT pretreatment and forskolin for 30 minutes.   Upon stimulation by forskolin, CRH neurons showed  a  significant  increase  (P<0.01)  in  TORC2  activation,  as  measured  by  nuclear  transl‐ocation (Figure 9, Figure 10).  This procedure was also performed in the presence of CORT, and showed similar trends as in the absence of CORT.  This indicates that TORC2 is not responsive to 2 hr of CORT pretreatment but is responsive to cellular stimulation by forskolin.  If in vivo studies reflect the findings of this preliminary in vitro study, then TORC2 should be responsive to acute psychological stress (i.e. cellular stimulation of the CRH neuron), but not to phasic glucocorticoid negative feedback, and possibly not to tonic glucocorticoid secretion either.  
Preliminary Experiment 2: perfusion vs. post­fixation as the tissue preservation method for optimal 
hypothalamic TORC2 immunostaining pilot study   The main  purpose  of  this  study was  to  enhance  tissue  fixation  conditions  as well  as  to begin optimizing TORC2 characterization.  TORC2 has been consistently difficult to characterize, which has remained true throughout all of  the studies  for  this project.   There have been many difficulties  with  the  fluorescence  immunohistochemistry  staining  procedure  (see  methods)  in regards to tissue integrity, high levels of background, and quality of the signal.     Paraformaldehyde  (PFA)  fixation  of  brains  (as  opposed  to  flash‐freezing  in  isopentane) produces better image quality for TORC2, therefore it is the preferred method of tissue fixation.  This  experiment  used  two  methods  to  seek  an  optimal  tissue  preservation  method  – paraformaldehyde  vascular  perfusion  and  tissue  post‐fixation.    Both  methodologies  involve  a PFA  incubation  period,  the  duration  of  which  is  discussed  in  the  following  paragraph.    The difference between the two is that in the former method, 4% PFA solution is injected into a live, anesthetized animal via the left ventricle and allowed to disseminate into the capillary beds of all tissues  (including  the  brain),  thus  preserving  the  tissue.    Post‐fixation,  on  the  other  hand, requires that the brain be extracted immediately post‐decapitation, blocked (using a razor blade) around the hypothalamus, and placed into PFA (12).   Prior to this experiment, the best duration of fixation in PFA solution was established to optimize both  tissue  integrity and staining quality.   The  tissue must be well enough preserved that it can endure numerous washes and extended incubation periods in PBS‐solutions required 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for  immunohistochemistry.    If  the  tissue  has  not  been  fixed  in  PFA  for  long  enough,  it  could degrade throughout the procedure (either partially or entirely), which makes cell quantification difficult.  However, if the tissue is in PFA for too long, the amount of background in the signal is dramatically higher.  Various durations of fixation incubation ranging from 4‐18 hours have been tested in studies not mentioned in this paper.  It appears that 8‐10 hours yields the most optimal condition  for staining while preserving  tissue  integrity, and  this duration was utilized  for both the perfusion and post‐fixation procedures.  The brains then underwent the normal post‐fixation and immunohistochemistry procedures (see methods section for a detailed protocol), using both diaminobenzidine (DAB) immunoprecipitation and immunofluorescence dual staining.    Although vascular perfusion produced better staining quality and tissue integrity,  it was later decided that  the procedure produces  too much of a confounding variable (for  the control group) to be used in stress research.  The anesthetization procedure was probably very stressful for the animals – the intraperitoneal injection or invasion of the chest cavity (both are physical stressors)  could  have  activated  the  HPA  axis;  even  pentobarbital  (the  drug  used  for anesthetization) is a potent activator of the HPA axis (26).  This variable may have accounted for the  large amount of variability  in TORC2 immunoreactivity patterns within the perfused‐group tissue, the data from which was not valuable because of this range of values.  However, the post‐fixation  method  utilized  in  this  experiment,  in  which  the  brains  were  blocked  around  the hypothalamus  and  immersed  in  PFA  for  10  hours,  appeared  optimal  for  both  integrity  and staining quality without significant stress to the animals.  Cells for both DAB‐ and fluorescence‐stained  tissue  were  quantified  and  analyzed,  and  although  the  test  groups  were  small,  some useful and interesting data were gathered.     This  experiment  had  a  “pseudo”‐2x2  design,  which  assigned  4  animals  per  test  group (N=16)  with  independent  variables  of  perfusion  and  30  minutes  of  restraint  stress  (it  is important to note that we were not looking for significant differences or an interaction between groups  –  it was  for  the  purposes  of  exploring  fixation methods  only).    The  reason  stress was included as an independent variable was to ensure that the TORC2 staining for both home‐cage and  restraint‐stress  conditions  were  optimal.   While  the  original  groups  contained  4  animals each, there was another unintentional variable that was not discovered until analysis: the time of day when the brains were harvested (the experiment took place between 1200 and 1600h).  The animals sacrificed towards the end of the testing period were killed closer to times that approach 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the circadian elevation in glucocorticoid secretion.  This became apparent when the groups were split between brains harvested before and after 1400h.  While this variable was accidental, there was a surprising difference in TORC2 activity between the two time points. Because time of day came to be viewed as an additional independent variable, the group sizes were reduced to only 2 animals, which unfortunately do not have a high level of statistical power.   Even so, there were some interesting, statistically significant differences between test groups.   Before  discussing  these  differences,  it is  important  to  appreciate  the  distinction between  DAB  and  fluorescence  IHC  in  this study.  In the DAB‐stained sections, the entire PVN,  except  magnocellular  neurons,  was quantified,  while  in  fluorescence  IHC,  only CRH‐positive  neurons  were  analyzed.    The data  actually  did diverge between  these  two methods;  the  fluorescent  sections  did  not yield  statistically  significant  differences between  any  groups,  while  the  DAB‐stained sections did.  For the DAB sections, there was a  difference  observed  between  both  time  of day (both groups were of the home cage [HC] cohort) and restraint‐stress (all before 1400h to eliminate this variable)(P<0.05 in both instances)(Figure 11).  Although the statistical power for these  groups  is  limited,  they  were  statistically  significant,  which  encouraged  further  study  of stress‐induced TORC2 nuclear translocation.   
 






there was a final run that included all animals and PVN containing tissue sections.  Data (Figure 12) from this experiment do not show a significant difference between test groups, but there was a strong trend (p=0.067).  Although the data were not significant, it seemed viable that this was due  to  the  fact  that  the group sizes were not  large enough  to yield sufficient  statistical power.  Consequently, this trend was strong enough to suggest that it is likely in a larger population set that  there  would  be  statistically  significant  differences  in  percent  nuclear  TORC2  between stressed  and  non‐stressed  animals,  the  measure  investigated  in  the  main  experiment  of  this project.  





stressed groups.   In the main study, we anticipated seeing an increase in percentage of nuclear TORC2  in CRH neurons with acute psychological  stress, an  increase  in nuclear TORC2  in basal levels of ADX animals, and a likely increase in stress‐induced TORC2 activation of ADX animals compared with all other groups, all of which reflect trends in crh gene expression data.  
Methods 
Subjects   Subjects  were  young  adult  male  Sprague‐Dawley  rats  from  Harlan  Labs  (Indianapolis, Indiana), weighing  between  260  and  300  grams  at  the  time  of  experimentation.    The  animals were housed in pairs in polycarbonate tubs (47 cm x 23 cm x 20 cm) with access to water and rat chow ad  libitum.    They were  held  in  four  different  suites, which were  separate  from  the  area where both  testing and sacrifice occurred.   The housing  rooms were maintained on a 12‐hour light/dark cycle (lights on at 0700h) and room temperature was held between 20°C and 24°C.  Rats were allowed a 2‐week acclimation period between arrival and the first testing procedures (surgeries).    All  care,  handling,  and  use  of  animals  followed  ethical  guidelines  posed  by  the University of Colorado Institutional Animal Care and Use Committee and adhered to the National Institutes of Health Guide for Care and Use of Laboratory Animals.  
Experimental Procedure    The experiment used a 2x2 factorial design, the independent variables being the presence of  endogenous glucocorticoids and exposure  to acute psychological  stress  (n=6, N=24).   Three days  before  testing,  the  rats  underwent  surgical  procedures  to  have  their  adrenal  glands removed,  resulting  in  two  glucocorticoid  test  groups.    One  half  of  the  rats  were  bilaterally adrenalectomized via two dorsal lateral incisions under halothane anesthetization, and belonged to  the  group  referred  to  as  the  ADX  group.    The  rats  that  were  to  remain  adrenal‐intact  still endured a surgery, called a sham surgery,  in which all surgical procedures matched that of the ADX group except the adrenals were left in place.  The sham surgeries controlled for the stress of surgery.   All  rats were administered Baytril  antibiotic  (1.2 mL antibiotic  in 10 mL 0.9% saline solution)  immediately  following surgery.   Between surgery and  testing, ADX rats were given a 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0.9% saline solution as their primary source of drinking water in order to compensate for their inability to retain ions and water as a result of the removal of endogenous aldosterone.   Testing  took  place  1‐3  hours  after  onset  of  the  light  portion  of  the  rats’  photoperiod. Testing began one hour after  lights on (0800h) to ensure that all adrenal‐intact animals’ CORT levels were at the lowest diurnal levels. Half of the rats (half ADX, half sham) were exposed to a 15‐minute acute restraint stress challenge.   The rest of the animals (half ADX, half sham) were left in their home cages until sacrifice (HC group).    
Restraint Stress Challenge Rats in the stress challenge cohort were placed in plexiglass cylindrical containers (23.5 cm long, with  a  diameter  of  7  cm, with  several  air  holes)  for  15 minutes  directly  preceding  tissue  and blood  collection.    Restrainers  prevented  major  movement,  but  allowed  normal  breathing.  Restraint stress took place in a room adjacent to, but separate from, the housing suites.  
Tissue and blood collection   Rats  were  taken  either  directly  from  their  home  cages  or  from  the  restrainers  and immediately decapitated with a guillotine.  Animals were sacrificed without anesthesia, as it is a powerful activator of the HPA axis (26).  Trunk blood was collected into EDTA‐coated (prevents coagulation) test tubes from Becton‐Dickinson (Franklin Lakes, New Jersey, USA) and placed on ice.  Plasma (containing ACTH) was separated from blood cells by centrifugation for 15 minutes at 4°C, and stored for the ACTH radioimmunoassay in 125‐µL aliquots at ‐80°C.     The fixation method for brain tissue is adapted from the methods described in a paper by Kahn and Watts (2004).  Brains were extracted from the skull, blocked in coronal pieces around the  hypothalamic  sulci  between  the  optic  chiasm  and  mamillary  bodies,  and  placed  in  glass scintillation vials containing 4% PFA (pH 7.4) for approximately 10 hours at 4°C on a shaker to ensure  penetration  of  PFA.    The  brain  sections  were  then  transferred  into  scintillation  vials containing 30% sucrose dissolved in a 0.1M PBS solution – a solution that enables cells to be in a healthy condition for storage.   After 48 hours of shaking in sucrose at 4°C, the brain tissue was taken out of sucrose and frozen  in tin  foil at  ‐80°C.   Brains were cut via cryostat (model 1850; Leica Microsystems, Nussloch, Germany) at ‐24°C into 25 µm‐thick coronal sections and stored 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in cryoprotectant (30% sucrose, 30% propylene glycol, 1% polyvinylpyrrolidone  in 0.01M PBS buffer, pH7.4) until immunohistochemistry staining.  
Radioimmunoassay   ACTH was measured (pg/ml) in duplicate (100 µl plasma) from plasma collected on test day.  This single‐staged RIA procedure is adapted from a previously established protocol (20,22).  125I  radiolabeled  ACTH  was  obtained  from  Diasorin  (Minneapolis,  MN,  USA);  primary  ACTH rabbit antiserum (Rb7,  final dilution 1:30,000) was donated by Dr. Bill Engeland (University of Minnesota).    The  assay  was  sensitive  to  ACTH  concentrations  of  ~15  pg/ml.    The  intraassay coefficient of variability was 6%.  
Fluorescence Immunohistochemistry   Dual staining of TORC2 and CRH was accomplished by fluorescence IHC.  All incubations were performed in 0.01M PBS buffer (pH 7.4) except the final washes, which were done in 0.01M PB buffer (because NaCl is autofluorescent).   Following the initial washes, the tissue endured a 30‐minute incubation in 0.1% Sodium Borohydride; this step is performed to reduce background fluorescence, however it is harsh on the tissue and reduces its integrity.  The initial “block” step utilized  a 10% normal  goat‐serum solution,  in  addition  to 3% dry milk  and 1% bovine  serum albumin  (which  reduce  non‐specific  binding),  and  0.3%  triton  X.    Primary  anti‐CRH  antibody (guinea  pig)  was  obtained  from  Penninsula  laboratories  (catalogue  number  T‐5007)  and was diluted to a final concentration of 1:15,000; the secondary antibody for CRH, goat anti‐guinea pig Ig,  was  tagged  with  Alexafluor  488  (Invitrogen  Molecular  Probes  catalog  number  A11073) diluted  1:1000.    Primary  anti‐TORC2  antibody  (rabbit)  was  obtained  from  Calbiochem laboratories (catalog number ST1099) and was diluted to a final concentration of 1:4000; TORC2 secondary  antibody was  goat  anti‐rabbit  Ig  tagged with  Alexafluor  594  (Invitrogen Molecular Probes  catalog  number  A11012)  diluted  1:1000.    Primary  antibodies  were  incubated simultaneously  for  ~48  hours,  shaking  at  4°C.    Secondary  antibodies  were  also  incubated simultaneously for 1 hour at room temperature.  After final PB washes, sections were mounted in a 1% glycerol PB solution onto microscope glass plus slides with ProLong Gold antifade reagent with Dapi (Invitrogen Molecular Probes, catalog number P36931). 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Image Analysis    Image capture, quantification, and analysis were all done blind to test groups.  PVN images were  captured  and  digitized  with  a  Zeiss microscope  at  400x magnification.    2‐color  channel fluorescent (mercury bulb illumination) photomicrographs of at least 4 PVN sections per animal were captured, using Axio‐Vision imaging software for both image capture and semiquantitative analysis.    Quantification  (done  blind  to  test  groups)  of  CRH  (green  channel)  and  TORC2  (red channel)  utilized  the  event  marker  tool  to  score  neurons  identified  as  CRH‐immunopositive; neurons were marked as CRH‐immunopositive if a clearly identifiable soma was present.  It was then  determined  if  each  CRH  neuron  was  also  TORC2‐immunopositive  by  roughly  the  same criterion.   Each TORC2 positively  immunoreactive neuron was  then qualitatively characterized as having predominantly cytoplasmic TORC2 versus predominantly nuclear TORC2.    A separate qualitative analysis was performed rating the “brightness” of CRH neurons in the PVN.  The analysis was done blind to test groups, and each image was rated on a subjective, 1‐5 scale of the brightness of the CRH neurons.  All images were captured within a 2‐hour time frame,  at  400x magnification  and  camera  exposure  time was  held  constant  at  200ms  for  each image.  
Statistical Analysis    All  statistical  tests  were  performed  using  the  SPSS  statistical  analysis  program  10.5 (Chicago, IL, USA) for Macintosh operating system. The data were first analyzed using two‐way ANOVAs  to  determine  whether  there  was  a main  effect  of  either  stress  or  adrenalectomy,  or whether there was an interaction between the two variables.  If there was a significant F‐value in any  instance,  Fisher’s  least  significant  difference  test  was  conducted  to  determine  pairwise comparisons of interest, α = 0.05. 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Results 
ACTH  levels  reflect  trends  observed  in  previous 
research   Although  ACTH  patterns  in  this  experi‐mental  setting  have  been  well  established,  data were  collected  in  this  study  to  validate  the effectiveness  of  the  acute  stress  and  ADX manipulations  on  HPA  axis  activity.    The  ACTH data  were  normalized  by  converting  values  to  a logarithmic  scale;  after  normalization  test  group differences were  as  expected.    There was  a main effect of stress (F1,23 = 54.152, p<0.05) and a main ADX  effect  (F1,23  =  102.389,  p<0.05).    Statistical results were confirmed by Fisher’s least significant difference (LSD) test.  This post‐hoc analysis also revealed a trend (p=0.065) of higher levels of ACTH in the no‐stress ADX group compared to the restraint‐stress sham group (Figure 13).  
CRH  production:  negative  correlation  with  endogenous 
glucocorticoids   As expected, the CRH immunofluorescence for ADX groups was rated significantly brighter than for the sham test groups (ADX effect: F1,21 = 85.804, p<0.05; Figure 14).  There  were  no  differences  in  brightness  of  CRH immunofluorescence between the no‐stress and restraint‐stress  conditions  within  the  sham  or  adrenalectomy cohorts. 


































final  preliminary  study  (see  preliminary  studies), there  was  no  significant  difference  between  the  no‐stress and  stress  condition.   This was an unexpected result, as our previous study had found a strong trend for  nuclear  translocation  of  TORC2  upon  HPA‐axis activation  via  acute  restraint  stress  (see  preliminary studies).  However, these results yielded a high degree of  variability  within  all  test  groups,  the  sources  of which will be addressed in the discussion.   
Discussion   In order  to  further  investigate and expand upon the 2010  in vitro  tissue culture studies done by Liu et. al (2010) and within the Spencer Lab (2010, unpublished) and preliminary in vivo studies, we utilized this 2x2 experimental design to observe the possible effects of acute stress and removal of endogenous glucocorticoids upon the activity o f TORC2 in CRH neurons.   Both of these treatment conditions produce well‐documented effects on HPA axis hormone secretion and crh gene expression (5,22). However, the testing conditions produced  no  significant  differences  in  nuclear  TORC2  levels  between  test  groups,  thereby challenging my hypothesis  that acute stress  induces  increased  levels of nuclear TORC2  in CRH neurons of adrenal‐intact animals.    I also expected to see a slight  increase of nuclear TORC2 in the non‐stressed ADX group, but the mean level for this group was slightly lower than those of the  other  groups.    Before  discussing  the  TORC2  data,  it  is  important  to  evaluate  the  other dependent variables in order to assess the likelihood of accuracy of the TORC2 data.     




lack  of  negative  glucocorticoid  negative  feedback  within  the  15‐minute  time  frame,  although feedback would not normally be seen at this time point (Figure 3).   Therefore, the unregulated phasic  secretion  of ACTH  in ADX  animals may be  due  to  removal  of  the  permissive  actions  of tonically  secreted  glucocorticoids  (e.g.  increased  levels  of  CRH  peptide  stored  in  the  median eminence  causes  increased  ACTH  secretion).    Research  also  indicates  that  adrenalectomy induces  increased sensitivity of CRH neurons at  the signal  transduction  level, which  is another interesting  possible  explanation  for  the  increase  in  restraint‐stress  levels  of  ACTH  in adrenalectomized animals (9).  





between  the  cellular  location  of  TORC2  in  CRH  neurons  of  unstressed  and  stressed  animals.  Because crh gene transcription has been shown to peak at 15 minutes of restraint stress (5), in theory TORC2 activity should increase in response to restraint‐stress in both the sham and ADX conditions, which was not observed in this study.  If the data from this experiment show the true nature of TORC2 activity in the PVN, then it can be concluded that TORC2 is not responsive to 15 minutes of restraint stress in vivo.     The ACTH data are consistent with normal HPA activity  indicating cellular activation of CRH neurons to some extent.   This, coupled with an increase in CRH peptide production in the absence  of  glucocorticoids,  shows  that  there  are  both  genomic  and  regulatory  changes  in  the HPA axis in response to acute psychological stress and tonic secretion of glucocorticoids.  There was  no  difference  between  nuclear  TORC2  levels  for  either  group  within  the  ADX  cohort, indicating  that  the removal of  tonic glucocorticoid secretion does not have an effect on TORC2 activity  in CRH neurons.   The preliminary  in vitro study showed a similar  trend  in  that adding CORT to the culture did not produce differences in TORC2 activation, as compared with vehicle (Figure 9).  However this method may be more applicable to the impacts of phasic glucocorticoid secretion, the effects of which are probably not yet evident with 15 minutes of restraint stress.  The  combination of  these data  sets  strongly  indicate  that  tonic  secretion of  glucocorticoids do not influence TORC2 activity.  However, the fact that there were no differences in restraint stress for  either  the  sham  or  adrenalectomy  cohorts  was  surprising,  as  this  is  inconsistent  with previous findings (Figure 12).   Liu et. al published a study in 2011 which investigated TORC2 activity in the PVN in vivo with an experimental design similar to that of this project, however Liu et. al used dramatically different  restraint‐stress  time  points  for  their measures.    In  this  study  by  Liu  et.  al  rats were restrained for one hour, removed from stress, and then sacrificed either 30 or 240 minutes after being taken out of restrainers and returned to their home cage.  The data showed robust nuclear TORC2 percentages in the dorsolateral PVN (using DAB immunohistochemistry) at 30 minutes, but not at 240 minutes (p<0.01).  The study also utilized chromatin immunoprecipitation assays for  TORC2  antibodies,  and  found  an  increase  in  TORC2  binding  to  crh  promoter  DNA  at  30 minutes, but not 240 minutes (p<0.01) (17).   This shows that there is TORC2 activity in vivo  in response to restraint stress, but perhaps on a different time scale than what was measured in the project for this paper.  However, it is still difficult to relate this to the fact that activation of the 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PKA  pathway  is  required  for  both  TORC2  activation  and  crh  promoter  activity.    Cellular stimulation occurs instantaneously (within seconds) of the perception of stress, and is inhibited at 30 minutes of restraint stress as shown by a reduction of c­fos mRNA at this time point (5), yet Liu et. al showed both TORC2 and crh gene activity 90 minutes after the onset of stress.  Liu et. al (2011) did not give an explanation  for why both would occur 30 minutes after  the removal of restraint  stress  (90 minutes after  the onset of  stress).  It  is  important  to note,  though,  that  the highest average percentage of nuclear TORC2 Liu et. al observed was only about 60% (17).    With regards to the data obtained from this study, it is also possible that there were other important  variables  that  have  not  been  considered,  one  of  which  could  be  glucocorticoid negative  feedback  influence on  the cellular  location of TORC2.   Crh  gene expression returns  to normal levels after approximately 30 minutes of acute restraint stress (Spencer Lab, unpublished data  2009),  and  the  rapid  return  of  crh  gene  expression  to  basal  levels  may  be  due  to glucocorticoid  negative  feedback.    At  fifteen minutes  after  the  onset  of  stress  (as  it may  be  – glucocorticoids could be synthesized, released, and in the brain by this time),  it  is possible that glucocorticoids play a role in exporting TORC2 out of the nucleus, thereby terminating crh gene transcription.    This  would  not  contradict  crh  gene  transcription  data  –  even  if  actual transcription had ended by 15 minutes of  restraint  stress  (which  is when crh gene expression peaks), there could still be previously synthesized hnRNA in the nucleus.    If this were the case, then levels of nuclear TORC2 should be higher prior to 15 minutes of restraint stress, which has not been  indicated thus  far.   However, both the  first and the  third preliminary studies showed that  TORC2  was  highly  nuclear  in  hypothalamic  neurons  30  minutes  after  administration  of forskolin or restraint stress, respectively (Figure 9, Figure 12), makes this explanation unlikely.  In addition, a widely accepted mechanism for feedback is that occupied glucocorticoid receptors prevent further transcription of crh gene by binding directly to the DNA at an nGRE (11), making it unlikely  that crh  gene  transcription  is directly  regulated by TORC2 being exported  from  the nucleus.   While these proposals are worthy of consideration, there was also a high degree of intra‐group  variability  in  this  experiment,  and  it  is  important  to  appreciate  the  differences  seen  in individual animals within test groups.   The ranges for the data are as follows: sham/NS = 9.64‐40.0%, sham/RS = 16.1‐47.0%, ADX/NS = 4.6‐31.3%, and ADX/RS = 9.6‐53.6% nuclear TORC2 in CRH neurons.   There are obvious differences  in nuclear TORC2 between individuals within the 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same  test  group,  as  exemplified  by  Figure  17. Because  there  was  a  high  degree  of  variability within  test  groups,  the  validity  of  these  results may be questionable, therefore it was important to  investigate  this  possibility.    The  differences could  be  attributed  to  individual  genetic differences  of  the  animals,  and  could  be manifested  in  either  the  individual  animal’s interpretation of  the  stressful  event or  the  time scale  of  various  intracellular  processes.    TORC2 values  were  compared  with  ACTH  concen‐trations  (which  indicate  the  degree  HPA  axis activity) using the Pearson correlation coefficient test, which revealed no significant correlation.  It may  also  be  viable  that TORC2  is  responsive  to  some other,  unknown variable  that  has  not been identified.   




  Another weakness  of  this  experiment  is  that  data  reflecting  crh  gene  transcription was not  collected.    The  way  that  tissue  is  preserved  to  enhance  immunohistochemistry  staining, which  is  10‐hour  post‐fixation  followed  by  storage  in  cryoprotectant,  makes  it  virtually impossible to collect data about RNA levels.  Although it is still useful to compare averages for crh hnRNA  levels  of  other  studies,  it would  have  been  useful  to  have  data  points  from  individual animals from this study in order to explore if there is a correlation between crh gene expression and TORC2 activity.   Although error may contribute to the negative results of the study, it is also important to consider the nature of the TORC2 protein observed up to this point.  In no‐stress conditions, the average amount of TORC2 found within the nucleus of CRH neurons hovers at around 15%, and the average for the stress condition in studies showing significant differences in percent nuclear TORC2  is  only  at  about  30%,  with  the  highest  percentages  at  around  50%.    If  TORC2  is  a coactivator of pCREB and is required for crh gene transcription as suggested by Liu et. al (2009, 2010), then levels of stress‐induced TORC2 nuclear translocation seem surprisingly low, even in the stress condition when crh gene transcription peaks (5).   HPA axis activity and CRH peptide upregulation  both  indicate  that  there  were  differences  in  hormonal  and  genomic  action,  but TORC2 appeared largely unresponsive to any of the testing conditions.  This may be an indicator that  TORC2  is  not  responsive  to  stress  or  glucocorticoids  in  vivo,  however  it  is  apparent  that further investigation is necessary.  
Future directions   Because  activation  of  PKA  by  forskolin  potently  induced  translocation  of  TORC2  to  the nucleus in vitro but this movement was not observed in vivo,  it  is safe to assume that there are other  factors  influencing  TORC2  activity  in  the  PVN.    An  interesting  study may  be  to  insert  a guide  cannula  directly  into  the  PVN  and  administer  either  vehicle  or  forskolin,  and  measure TORC2  translocation  under  both  stressed  and  non‐stressed  conditions.    It  would  also  be interesting to infuse vehicle or forskolin in a chronic manner, to observe if there are long‐term differences in hormonal (ACTH and CORT) activity in response to an increase in cellular activity of the CRH neuron.     A  finding  from  the  second preliminary  study  that  has  not  been  addressed  is  the  highly significant increase in nuclear TORC2 at different times of day.  In this small study, there was a 
  30 high  percentage  of  nuclear  TORC2  in  brains  harvested  after  1400h,  which  may  indicate  a relationship of TORC2 activity to circadian rhythms.  This is also supported by increases in both 
crh  and  c­fos  gene  expression,  as  shown  by  Girotti  et,  al  (Figure  6,  Figure  7).    It  would  be interesting to examine the activity of TORC2 over a time course throughout the day to see if there are diurnal differences in its cellular location.   Also,  because  Liu  et.  al  (2011)  saw  a  significant  increase  in  CRH  neurons with  nuclear TORC2 at a much later time point than was studied in this project,  it would be useful to have a restraint‐stress time course at time points between 0 and 240 minutes.  An interesting analysis for this (and other) suggested study would be to investigate TORC2 activity in other regions of the brain, such as the hippocampus and amygdala where TORC2 is also found.   Finally,  because  TORC2  location  characterization  has  proven  to  be  difficult,  it  may  be useful  to  explore  better  methods  of  staining  and  analysis.    One  of  these  methods  might  be examination  of  colocalization  of  TORC2,  CRH,  and  DAPI, which  is  a  DNA  stain  that marks  the nucleus  of  all  cells.    A  second method  for  improving  TORC2  characterization would  be  to  use confocal microscopy, which provides a higher‐resolution image of individual planes of the tissue slices,  making  identification  of  cellular  locations  more  straightforward.    This  would  use fluorescence IHC, and overlapping images taken of these different molecular signals may assist in characterization  of  TORC2  location.    It  would  also  be  useful  to  establish  a  method  of  tissue fixation in which both immunohistochemistry as well as in situ hybridization can be used, which would allow TORC2 and crh gene expression to be measured in the same animal. 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